[Disseminated intravascular coagulation associated with sepsis]

Area of Science:

• Critical Care Medicine
• Hematology
• Infectious Diseases

Background:

• Sepsis is life-threatening organ dysfunction due to dysregulated host responses to infection.
• Infectious diseases can shift the prothrombotic/antithrombotic balance towards a prothrombotic state, a defense mechanism.
• Uncontained prothrombotic responses in severe infections lead to sepsis-associated disseminated intravascular coagulation (DIC) and organ damage.

Purpose of the Study:

• To review the role of anticoagulation in managing sepsis-associated DIC.
• To highlight current Japanese clinical practice guidelines for sepsis and DIC management.
• To identify areas for further discussion regarding optimal anticoagulation strategies in sepsis.

Main Methods:

• Review of current literature and clinical practice guidelines.
• Analysis of the pathophysiology of sepsis-associated DIC.
• Evaluation of treatment recommendations for sepsis-associated DIC.

Main Results:

• Sepsis-associated DIC involves extensive ischemic organ damage.
• Anticoagulation therapy can alleviate ischemic organ damage in sepsis-associated DIC.
• Japanese guidelines recommend antithrombin or recombinant thrombomodulin for sepsis-associated DIC.

Conclusions:

• Anticoagulation is a potential therapeutic strategy for sepsis-associated DIC.
• Current guidelines suggest specific agents for treatment.
• Further research is needed to optimize patient selection and treatment methods for anticoagulation in sepsis-associated DIC.